CANCER BREAKTHROUGH

With our FDA-approved CAR-T cell therapy, we're changing how the world fights cancer.

Proton therapy cyclotron
The Benefits of Proton Therapy

More precise therapy. Less side effects. Better quality of life. Learn more.

Lymphocytes attacking cancer cell
Pioneering Immunotherapy

The FDA recently approved Penn's CAR-T therapy — the first of its kind — for pediatric and young adult leukemia. Read the news release or call 215-316-5127 for more information.

Dr. Porter at work
Penn Immunotherapy in the News

View the latest news stories about our game-changing immunotherapy treatments and research.

US News and World Report Badge
Top Cancer Hospital in the Nation

We are ranked #1 in the Philadelphia region and 7th in the nation for cancer care by U.S. News & World Report.

Clinical Trials Quick Search:

Is CAR-T Therapy Right For Me?

CAR-T is now available to treat adults, ages 18 to 25, with acute lymphoblastic leukemia (ALL). Whether you are newly diagnosed or looking for a second opinion, request a call back and find out if CAR-T is right for you.

Request a Call-Back

We also have CAR T therapy clinical trials available for lymphoma, melanoma, pancreatic cancer, breast cancer, brain cancer and many others.